Combining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protection
about
Post-Genomics and Vaccine Improvement for LeishmaniaNoninvasive Diagnosis of Visceral Leishmaniasis: Development and Evaluation of Two Urine-Based Immunoassays for Detection of Leishmania donovani Infection in India.Identification of BALB/c Immune Markers Correlated with a Partial Protection to Leishmania infantum after Vaccination with a Rationally Designed Multi-epitope Cysteine Protease A Peptide-Based Nanovaccine.Vaccine potential of HLA-A2 epitopes from Leishmania Cysteine Protease Type III (CPC).Delivery systems for Leishmania vaccine development.Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani.Liposomal formulations in the pharmacological treatment of leishmaniasis: a review.Correction: Combining Cationic Liposomal Delivery with MPL-TDM for Cysteine Protease Cocktail Vaccination against Leishmania donovani: Evidence for Antigen Synergy and Protection.Identification of Potential MHC Class-II-Restricted Epitopes Derived from Leishmania donovani Antigens by Reverse Vaccinology and Evaluation of Their CD4+ T-Cell Responsiveness against Visceral Leishmaniasis.Liposomal Elongation Factor-1α Triggers Effector CD4 and CD8 T Cells for Induction of Long-Lasting Protective Immunity against Visceral Leishmaniasis.Alternative to Chemotherapy-The Unmet Demand against Leishmaniasis.Immunoprophylactic Potential of a Cocktail of Three Low Molecular Weight Antigens of Leishmania donovani along with Various Adjuvants Against Experimental Visceral leishmaniasis.
P2860
Q26752532-6788B49C-C6DD-4C6D-86B9-27A82ECC09D8Q36163680-2383FEF7-ABE6-4BA2-92EC-5B40C1499289Q36257481-21C4AD1A-C766-47EC-A086-96A6BEB25294Q38700268-6783B9D0-B967-4159-A6F3-4E5363DEB370Q38746362-63E87063-E202-4367-BB50-48020C699F54Q41678461-A8494C04-725E-4EEC-A11A-D95937D65552Q43168913-8E8BE930-A3F9-46DC-BAD4-430B9F51071AQ43204101-159941E7-1E75-4767-877F-838804EEC840Q47201994-5D6FAA8E-6D21-497F-8C6D-15338F9D9075Q49210114-FF074372-0EFB-45F7-9F34-387DE5AABC36Q50130388-B786A6BE-420C-4011-B743-5D480FF64CABQ55405901-B8DC7F59-D70E-47C8-81C7-349954E7ED53
P2860
Combining cationic liposomal delivery with MPL-TDM for cysteine protease cocktail vaccination against Leishmania donovani: evidence for antigen synergy and protection
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Combining cationic liposomal d ...... antigen synergy and protection
@ast
Combining cationic liposomal d ...... antigen synergy and protection
@en
Combining cationic liposomal d ...... antigen synergy and protection
@nl
type
label
Combining cationic liposomal d ...... antigen synergy and protection
@ast
Combining cationic liposomal d ...... antigen synergy and protection
@en
Combining cationic liposomal d ...... antigen synergy and protection
@nl
prefLabel
Combining cationic liposomal d ...... antigen synergy and protection
@ast
Combining cationic liposomal d ...... antigen synergy and protection
@en
Combining cationic liposomal d ...... antigen synergy and protection
@nl
P2860
P3181
P1476
Combining cationic liposomal d ...... antigen synergy and protection
@en
P2093
P2860
P3181
P356
10.1371/JOURNAL.PNTD.0003091
P407
P577
2014-08-21T00:00:00Z